Stanford
Gates Foundation Awards Multiple Grants for Omics, Dx Projects in August
Awardees include Quantigen, Sherlock Biosciences, the Netherlands National Institute for Public Health and the Environment, Stanford University, and Rutgers University.
New Data in Kidney Cancer Bolsters Promise of Mass Spec Technique for Assessing Surgical Margins
Premium
Investigators hope they can establish the technology in kidney cancer and other tumor types to improve surgery success and associated survival outcomes.
Germline Genetic Testing Rates in Cancer Patients Low in California, Georgia, Study Finds
Only about 7 percent of cancer patients underwent testing, and rates were especially low among Black, Asian, and Hispanic patients.
POC Genotyping Tests Based on Electromagnetic Detection Tech Step out From Stanford University Lab
Premium
Spinout Magic LifeScience is leading commercialization of the molecular diagnostic technology, but the tests are popping up in other clinical scenarios, too.
The company believes the new results, from an initial prospective multisite trial, reflect what it can achieve in the larger cohort that it is now planning to recruit.